HealthInvestor UK Awards 2021 Finalist - Strategic & Transactional

About

Candesic is a leading strategy consultancy head-quartered in London, serving private operators, investors, and public sector organisations.

: Candesic proudly advised on Kester Capital investment
Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist in market access consulting services to the pharmaceutical and biotech sectors. The mission of MAP Patient Access Limited is to make it easier for patients to access ground-breaking medicines, devices, and diagnostics. In addition to its expertise in rare and orphan diseases, it has a proven track record of helping its clients navigate increasingly complex healthcare reimbursement pathways.

: HealthTechX Global 2023 was quite the event!
Thanks to all HealthTechX Global 2023- it was quite the event!

: Candesic visits Imperial College Business School ‎
This week our team visited Imperial College Business School. **Candesic** is a leading strategy consultancy providing CEO level clarity with R&D level insights for over 21 years.